Specialty Pharmacy

G-CSF promotes regeneration of sperm cells in cancer patients.

A majority of glioblastomas change their genomic profile during therapy, new research finds.

Targeting the interactions between neurons and cancer cells may be a powerful strategy in future cancer treatments.

Fixed-dose combination provides another oral treatment option for patients with diabetes.

Alternating gut microbiota in mice causes hypertension.

Top news of the day from across the health care landscape.

Researchers create a map of breast cancer cell shapes and genes that is linked to outcomes.

One-fourth of standard dose with low-fat meal as effective as standard dose.

Biologic HIV drug may reduce new infections among high risk populations.

The smallest Cas9 gene editing technique has been developed thus far.

Lynparza (olaparib) shows efficacy in a phase 3 clinical trial of BRCA-mutated HER2-negative metastatic breast cancer.

New technology can predict which patients will achieve remission and which will relapse.

Top news of the day from across the health care landscape.

Top news of the week in oncology and cancer drug development.

The Akt protein is crucial for T cells to transform into memory T cells.

Parameters used to calculate direct and indirect remuneration fees may not apply to specialty pharmacies.

SF2523 can dually inhibit a protein and an enzyme associated with cancer.

Prescription drug spending expected to increase from 2017 to 2025 due to costly specialty drugs.

Patients who experienced side effects were 3 times more likely not to meet LDL cholesterol targets.

Cannabidiol found in cannabis could be used as a novel treatment for hepatitis C virus

Top news of the week from Specialty Pharmacy Times.

Cancer cells adjusted to have normal circadian rhythm slowed tumor growth.

The Iowa Department of Public Health released its first report on hepatitis C virus.

Extrachromosomal oncogene helps drive tumor evolution and heterogeneity.

Statins among promising treatment options helping to progress the HIV treatment landscape.

Central nervous system lesions may impede cognitive and sensorimotor function in patients with MS.

Novel class of inhibitors may be used as a preventive measure for HIV in the future.

Lenalidomide (Revlimid) maintenance improved survival in multiple myeloma patients following a stem cell transplant.